Cancer

You have access
Symptom Burden in Patients Treated With Palliative Radiotherapy Before and During the COVID-19 Pandemic
CARSTEN NIEDER, SILJE K. JOHNSEN and ANNETTE M. WINTHER

Anticancer Research April 2021, 41 (4) 1971-1974; DOI: https://doi.org/10.21873/anticanres.14964
You have access
Impact of the Regional Palliative Care Pathway on Emergency Room Visits and Hospitalizations
OLLI HALTIA, OUTI M. HIRVONEN, TIINA SAARTO and JUHO T. LEHTO

Anticancer Research March 2021, 41 (3) 1701-1706; DOI: https://doi.org/10.21873/anticanres.14934
You have access
Reversion from Methionine Addiction to Methionine Independence Results in Loss of Tumorigenic Potential of Highly-malignant Lung-cancer Cells
JUN YAMAMOTO, YUSUKE AOKI, QINGHONG HAN, NORIHIKO SUGISAWA, YU SUN, KAZUYUKI HAMADA, HIROTO NISHINO, SACHIKO INUBUSHI, KENTARO MIYAKE, RYUSEI MATSUYAMA, MICHAEL BOUVET, ITARU ENDO and ROBERT M. HOFFMAN

Anticancer Research February 2021, 41 (2) 641-643; DOI: https://doi.org/10.21873/anticanres.14815
You have access
Lymphocytes, Interleukin 6 and D-dimer Cannot Predict Clinical Outcome in Coronavirus Cancer Patients: LyNC1.20 Study
GIANLUCA VANNI, MARCO MATERAZZO, MARIO DAURI, ANDREA FARINACCIO, CHIARA BUONOMO, ILARIA PORTARENA, MARCO PELLICCIARO, JACOPO MARIA LEGRAMANTE, STEFANO RIZZA, CARLO CHIARAMONTE, ALFONSO BELLIA, MICHELE GRANDE, SAVERIO POTENZA, FRANCESCO PAOLO SBORDONE, MARCO ALFONSO PERRONE, FRANCESCO GRIMALDI, MARCELLO CHIOCCHI and ORESTE CLAUDIO BUONOMO

Anticancer Research January 2021, 41 (1) 307-316; DOI: https://doi.org/10.21873/anticanres.14777
You have access
The Role of Zyxin in Carcinogenesis
ALEKSANDRA PARTYNSKA, AGNIESZKA GOMULKIEWICZ, PIOTR DZIEGIEL and MARZENNA PODHORSKA-OKOLOW

Anticancer Research November 2020, 40 (11) 5981-5988; DOI: https://doi.org/10.21873/anticanres.14618
You have access
The Development of Next-generation PBMC Humanized Mice for Preclinical Investigation of Cancer Immunotherapeutic Agents
Y. MAURICE MORILLON, ARIANA SABZEVARI, JEFFREY SCHLOM and JOHN W. GREINER

Anticancer Research October 2020, 40 (10) 5329-5341; DOI: https://doi.org/10.21873/anticanres.14540
You have access
Highly Activated Ex Vivo-expanded Natural Killer Cells in Patients With Solid Tumors in a Phase I/IIa Clinical Study
KAZUHIRO NAGAI, YUI HARADA, HIROSHI HARADA, KATSUNORI YANAGIHARA, YOSHIKAZU YONEMITSU and YASUSHI MIYAZAKI

Anticancer Research October 2020, 40 (10) 5687-5700; DOI: https://doi.org/10.21873/anticanres.14583
You have access
The Induction of Antioxidant Catalase Enzyme With Decrease of Plasma Malonidialdehyde: An Important Reactive Oxidative Species Inhibiting Mechanism
MAIJU RUOTTINEN, VIIVI KAARONEN, IINA SAIMANEN, VIIVI KUOSMANEN, JARI KÄRKKÄINEN, TUOMAS SELANDER, SAMULI ASPINEN and MATTI ESKELINEN

Anticancer Research October 2020, 40 (10) 5701-5706; DOI: https://doi.org/10.21873/anticanres.14584
You have access
Angiosarcomas of Primary Gynecologic Origin – A Case Series and Review of the Literature
LUKAS CHINCZEWSKI, ELIANE TABEA TAUBE, FELIX WILHELM FELDHAUS, LISA ANTONIA DRÖGE, RADOSLAV CHEKEROV, MUSTAFA ZELAL MUALLEM, KLAUS PIETZNER, JALID SEHOULI and SARA ALAVI

Anticancer Research October 2020, 40 (10) 5743-5750; DOI: https://doi.org/10.21873/anticanres.14590
You have access
Luteolin Induces Cytotoxicity in Mix Cellularity Classical Hodgkin's Lymphoma via Caspase Activated-cell Death
RAJENDRA GHARBARAN, ENYUAN SHANG, ONYEKWERE ONWUMERE, NAOMI CODRINGTON, EVANGELINA DANKWA SARPONG and STEPHEN REDENTI

Anticancer Research September 2020, 40 (9) 4907-4912; DOI: https://doi.org/10.21873/anticanres.14493

Main menu

User menu

Search

Cancer

Pages